Persistent hyperplastic primary vitreous in association with neurofibromatosis 2

Journal of Pediatric Ophthalmology and Strabismus

Volumn 42, Issue 4, 2005, Pages 247-249

  Nguyen, Dan Q ^a   Chatterjee, Sudeshna ^a   Bates, Richard ^b  

^a MUSGROVE PARK HOSPITAL   (United Kingdom)

^b MILTON KEYNES GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTROCYTOMA; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; CATARACT; EPENDYMOMA; EYE FUNDUS; EYE INJURY; FAMILY HISTORY; GENETIC ANALYSIS; HUMAN; MALE; MENINGIOMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSISTENT HYPERPLASTIC PRIMARY VITREOUS; PHYSICAL EXAMINATION; SCHOOL CHILD; SLIT LAMP; VERTICAL TRANSMISSION; VISUAL ACUITY; VITREOUS BODY;

ADULT; CHILD; DISEASE TRANSMISSION, VERTICAL; EYE ABNORMALITIES; HUMANS; HYPERPLASIA; MALE; NEUROFIBROMATOSIS 2; VITREOUS BODY;

EID: 23044473350     PISSN: 01913913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Goldberg MF. Persistent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. Am J Ophthalmol 1997;124:587-626.
2. Lin AE, Biglan AW, Garver KL. Persistent hyperplastic primary vitreous with vertical transmission. Ophthalmic Paediatr Genet 1990;11:121-122.
3. Haddad R, Font RL, Reeser F. Persistent hyperplastic primary vitreous: a clinicopathologic study of 62 cases and review of the literature. Surv Ophthalmol 1978;23:123-134.
4. Marshman WE, Jan JE, Lyons CJ. Neurologic abnormalities associated with persistent hyperplastic primary vitreous. Can J Ophthalmol 1999;34:17-22.
5. Anteby I, Cohen E, Karshai I, BenEzra D. Unilateral persistent hyperplastic primary vitreous: course and outcome. J Pediatr Ophthalmol Strabismus 2002;6:92-99.
6. Ragge NK, Baser ME, Klein J, et al. Ocular abnormalities in neurofibromatosis 2. Am J Ophthalmol 1995;120:634-641.
7. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesinezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumour suppressor. Cell 1993;72:791-800.
8. Consensus Development Panel. National Institute of Health consensus development conference statement on acoustic neuroma. Arch Neurol 1994;51:201-207.
9. Ragge NK, Baser ME, Riccardi VM, Falk RE. The ocular presentation of neurofibromatosis 2. Eye 1997;11(part 1):12-18.
10. Evans DG, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. QJ Med 1992;84:603-618.